Steven Elias, MD
Vascular Surgery · Englewood, NJNPI 1275587024
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $326,179 of the $509,230 with a category attached, or 64.1%. It is spread thinly across 20 manufacturers, the largest accounting for just 20.9%. Reporting peaked in 2019 at $150,425 and has fallen 55.0% since, to $67,634 in 2025. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $1686.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocompatibles, Inc.$107K
- Boston Scientific$106K
- Philips North America LLC$81K
- Medtronic$53K
- Bard Peripheral Vascular, Inc.$37K
- W. L. Gore & Associates, Inc.$35K
- plus $90K from 14 others
Across 29 payments — averaging $7024.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$90K
- Boston Scientific$62K
- Vesper Medical$37K
- Philips North America LLC$9K
- Angiodynamics, Inc.$5K
What the payments were for
- Consulting fees$326,17964%
- Speaking & faculty fees$162,07432%
- Grants$1,0000%
- Travel & lodging$12,9183%
- Food & beverage$7,0601%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocompatibles, Inc. | 5 | $106,636 |
| Boston Scientific | 86 | $106,313 |
| Philips North America LLC | 47 | $81,211 |
| Medtronic(2 entities) | 48 | $52,838 |
| Bard Peripheral Vascular, Inc. | 29 | $36,671 |
| W. L. Gore & Associates, Inc. | 6 | $35,262 |
| Merit Medical Systems Inc | 15 | $35,194 |
| Tactile Systems Technology Inc | 22 | $20,047 |
| Lemaitre Vascular, Inc. | 15 | $14,219 |
| Cook Incorporated | 5 | $10,860 |
| Angiodynamics, Inc. | 4 | $6,142 |
| Venclose Inc. | 1 | $2,000 |
| Inari Medical, Inc. | 4 | $893 |
| Cook Medical LLC | 6 | $418 |
| Kerecis Limited | 3 | $170 |
| Smith+Nephew | 2 | $146 |
| Vesper Medical | 1 | $87 |
| Shockwave Medical, Inc | 1 | $61 |
| Penumbra, Inc. | 1 | $36 |
| Organogenesis Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VARITHENA$111,886
- Product in Development$35,000
- VenaSeal$26,942
- Abre$22,964
- (6554) Periph Vasc Undiv$20,726
- (9520) IGT Devices Undivided$20,100
- Flexitouch Plus$18,738
- IGT D Peripheral$18,000
- Varithena Administration Pack$16,653
- GENERAL - THERAPIES$15,575
- GENERAL VASCULAR INTERVENTION$13,946
- CLINICAL TRIAL PRODUCT$13,750
- Entre Plus$13,284
- HYDRO LEMAITRE VALVULOTOME$10,000
- (8328) Image Guided Therapy Devices _ Therapy$7,500
- IGT D Coronary$7,112
- Clarivein$7,000
- (6554) Peripheral Vascular Undivided$4,800
- Cook Medical Stents$4,500
- ANGIOJET$4,500
How this compares
$509,230 in reported general payments places this provider in the 95th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $11,491 |
| XareltoRivaroxaban | 12 | $6,450 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Englewood
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
- Saum RahimiNew Brunswick$90K
- Michael LiebHainesport$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.